Capital Investment Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History

Capital Investment Advisory Services’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,690	Closed	-$91K	–	1240
2018 Q4	$91K	Buy	+1,690	New	+$86.2K	0.04%	325
2018 Q3	–	Sell	-8,609	Closed	-$359K	–	228
2018 Q2	$359K	Sell	8,609 -2,490	-22%	-$110K	0.18%	146
2018 Q1	$489K	Sell	11,099 -4,830	-30%	-$245K	0.27%	93
2017 Q4	$801K	Sell	15,929 -1,725	-10%	-$94.6K	0.47%	49
2017 Q3	$895K	Sell	17,654 -150	-0.8%	-$7.86K	0.55%	39
2017 Q2	$906K	Sell	17,804 -386	-2%	-$18K	0.6%	41
2017 Q1	$731K	Buy	18,190 +1,384	+8%	+$62.2K	0.54%	53
2016 Q4	$804K	Buy	+16,806	New	+$665K	0.7%	39

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Investment Advisory Services's IONS Position: Q1 2019 in Review

Capital Investment Advisory Services sold out of Ionis Pharmaceuticals (IONS) in Q1 2019, closing a stake of 1,690 shares — an estimated $91K sold.

Capital Investment Advisory Services first reported a position in IONS in Q4 2016 and held it in 8 quarters. The position peaked at $906K in Q2 2017. 392 funds tracked by Wall St. Rank hold IONS as of Q1 2019.

Capital Investment Advisory Services reported no remaining Ionis Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Capital Investment Advisory Services sold 1,690 Ionis Pharmaceuticals shares in Q1 2019, an estimated $91K.
Capital Investment Advisory Services first reported a position in Ionis Pharmaceuticals in Q4 2016 and held it in 8 quarters.
Capital Investment Advisory Services's Ionis Pharmaceuticals position peaked at $906K in Q2 2017.
392 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2019.

Based on Capital Investment Advisory Services's 13F filing for Q1 2019, filed 23 Apr 2019.